Divi's Laboratories Limited (NSE:DIVISLAB) Investors Are Less Pessimistic Than Expected
Apr 10
Have your own idea? Try our Stock Screener
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedApr 15, 2025
DataAggregated Company Financials
Companies19
- 7D5.3%
- 3M-9.5%
- 1Y37.0%
- YTD-11.5%
In the last week, the Life Sciences industry is up 5.3%, with Divi's Laboratories up 6.3%. This means that the industry has gained 37% over the past year. As for the next few years, earnings are expected to grow by 21% per annum.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 16 Apr 2025 | ₹2.5t | ₹287.4b | ₹30.8b | 43.3x | 80.3x | 8.6x |
| Fri, 14 Mar 2025 | ₹2.5t | ₹287.4b | ₹30.8b | 47x | 79.9x | 8.6x |
| Sun, 09 Feb 2025 | ₹2.7t | ₹286.2b | ₹30.2b | 52.8x | 89.7x | 9.4x |
| Tue, 07 Jan 2025 | ₹2.5t | ₹269.1b | ₹30.1b | 54.9x | 83.9x | 9.4x |
| Thu, 05 Dec 2024 | ₹2.5t | ₹254.2b | ₹28.8b | 49.6x | 86.7x | 9.8x |
| Sat, 02 Nov 2024 | ₹2.4t | ₹247.9b | ₹26.0b | 48.8x | 91.8x | 9.6x |
| Mon, 30 Sep 2024 | ₹2.3t | ₹247.6b | ₹26.3b | 49.6x | 86.7x | 9.2x |
| Wed, 28 Aug 2024 | ₹2.1t | ₹247.6b | ₹26.3b | 46.4x | 79.4x | 8.4x |
| Fri, 26 Jul 2024 | ₹1.8t | ₹201.7b | ₹23.8b | 40.9x | 77.1x | 9.1x |
| Sun, 23 Jun 2024 | ₹1.7t | ₹198.0b | ₹23.7b | 33.7x | 73.7x | 8.8x |
| Tue, 21 May 2024 | ₹1.6t | ₹193.9b | ₹21.6b | 35.8x | 73.3x | 8.2x |
| Thu, 18 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 28.9x | 76.4x | 8.4x |
| Sat, 16 Mar 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 29x | 71.3x | 7.9x |
| Mon, 12 Feb 2024 | ₹1.4t | ₹168.4b | ₹19.6b | 33.1x | 72x | 8.4x |
| Wed, 10 Jan 2024 | ₹1.5t | ₹155.9b | ₹18.1b | 23.9x | 80.5x | 9.3x |
| Fri, 08 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 23.3x | 76x | 8.8x |
| Sun, 05 Nov 2023 | ₹1.3t | ₹156.0b | ₹19.8b | 23.3x | 63.5x | 8x |
| Tue, 03 Oct 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.4x | 71.8x | 9.1x |
| Thu, 31 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26x | 69.3x | 8.8x |
| Sat, 29 Jul 2023 | ₹1.4t | ₹158.1b | ₹23.2b | 31.1x | 60.9x | 8.9x |
| Mon, 26 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28.5x | 56.2x | 8.2x |
| Wed, 24 May 2023 | ₹1.3t | ₹157.4b | ₹22.9b | 33x | 55x | 8x |
| Fri, 21 Apr 2023 | ₹1.2t | ₹159.5b | ₹28.4b | 32.2x | 41.4x | 7.4x |
| Sun, 19 Mar 2023 | ₹1.0t | ₹159.5b | ₹28.4b | 30.9x | 36.9x | 6.6x |
| Tue, 14 Feb 2023 | ₹1.0t | ₹159.6b | ₹28.4b | 34x | 36.6x | 6.5x |
| Thu, 12 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30.3x | 35.8x | 7.5x |
| Sat, 10 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30x | 34.5x | 7.2x |
| Mon, 07 Nov 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 37.4x | 36.9x | 8.1x |
| Wed, 05 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 37.1x | 36.8x | 8.1x |
| Fri, 02 Sep 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 37.9x | 35.9x | 7.9x |
| Sun, 31 Jul 2022 | ₹1.3t | ₹159.0b | ₹34.4b | 34.4x | 38.8x | 8.4x |
| Tue, 28 Jun 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.9x | 37.6x | 8.1x |
| Thu, 26 May 2022 | ₹1.2t | ₹149.6b | ₹34.0b | 31.6x | 36x | 8.2x |
| Sat, 23 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 36.6x | 52.5x | 10.4x |
Price to Earnings Ratio
52.5x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 80.3x which is higher than its 3-year average PE of 62.1x.
- The industry is trading close to its 3-year average PS ratio of 8.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 25% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 3.22% | |
| Healthcare | 2.73% | |
| Life Sciences | 5.34% | |
| Clinical Research and Equipment | 5.34% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹5.73k | 6.4% +₹92.2b | 52.3% | PE73.6x | |
| SAILIFE Sai Life Sciences | ₹771.05 | 13.2% +₹18.7b | n/a | PE116.5x | |
| SYNGENE Syngene International | ₹721.40 | 3.8% +₹10.6b | 1.5% | PE57.7x | |
| INDGN Indegene | ₹579.85 | 5.3% +₹7.0b | n/a | PE36.1x | |
| AKUMS Akums Drugs and Pharmaceuticals | ₹477.15 | 7.0% +₹4.9b | n/a | PE50.3x |
